Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Fuji
Farmers Insurance
Julphar
Chinese Patent Office
McKesson
US Department of Justice
Accenture

Generated: June 18, 2018

DrugPatentWatch Database Preview

LYMPHAZURIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lymphazurin, and what generic alternatives are available?

Lymphazurin is a drug marketed by Covidien and is included in one NDA.

The generic ingredient in LYMPHAZURIN is isosulfan blue. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.
Drug patent expirations by year for LYMPHAZURIN
Synonyms for LYMPHAZURIN
(4-(alpha-(p-(Diethylamino)phenyl)-2,5-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium hydroxide, inner salt, sodium salt
39N9K8S2A4
68238-36-8
AC1L18GW
AC1Q1VDY
AKOS015904521
AN-38145
CAS-68238-36-8
CHEMBL1200859
D04634
D0P2YD
DB09136
Disulphin Blau
DSSTox_CID_31594
DSSTox_GSID_57805
DSSTox_RID_97478
DTXSID8057805
Ethanaminium, N-(4-((4-(diethylamino)phenyl)(2,5-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide, inner salt, sodium salt
I14-17361
Iso-sulfan blue
ISOSULFAN BLUE
Isosulfan blue (USAN)
Isosulfan blue [USAN]
LS-186487
Lymphazurin (TN)
MFCD00867653
natrium-2-{[4-(diethylamino)phenyl][4-(diethyliminio)cyclohexa-2,5-dien-1-yliden]methyl}benzol-1,4-disulfonat
NCGC00253597-01
OR076619
P 1888
P 4125
P-4125
Patent blau V
Patentblau V
SCHEMBL3324345
Sodium 2-((4-(diethylamino)phenyl)(4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene)methyl)benzene-1,4-disulfonate
sodium 2-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
sodium 2-[[4-(diethylamino)phenyl]-(4-diethyliminiocyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
SODIUM BIS[4-(DIETHYLAMINO)PHENYL](2,5-DISULFONATOPHENYL)METHYLIUM
Sulfanblau
Sulphan Blue
Sulphan blue 2,5-disulfophenyl isomer
Tox21_113733
UNII-39N9K8S2A4

US Patents and Regulatory Information for LYMPHAZURIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covidien LYMPHAZURIN isosulfan blue INJECTABLE;INJECTION 018310-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
QuintilesIMS
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Chubb
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.